Cardiac Risk Assessment

2005 Tan
Prepared by: Hanny Tan, M.D. Updated: June 14, 2006
Cardiac Risk Assessment

Key Points: 1. Patients with a high cardiac risk index have a markedly increased risk of perioperative cardiac complications. 2. Take into consideration whether the surgery is elective or emergent. 3. Consider delaying or canceling surgery if a high risk patient can not be medically optimized prior to surgery.
Assessing Patient Specific Risk

Due to the mortality and cost from post-operative myocardial infarction and cardiac complications, ways to reduce mortality have been studied. The first step is to identify intermediate and high risk patients. For years, patients have been risk stratified into low, intermediate, and high for developing perioperative cardiac complications. In 1977 Goldman, et al., developed the first preoperative cardiac risk index by looking at nine variables (preoperative third heart sound or jugular venous distention; myocardial infarction in the preceding six months; more than five premature ventricular contractions per minute documented at any time before operation; rhythm other than sinus or presence of premature atrial contractions on preoperative electrocardiogram; age over 70 years; intraperitoneal, intrathoracic or aortic operation; emergency operation; important valvular aortic stenosis; and poor general medical condition),which increased the risk of perioperative cardiac complications10. Since 1977, multiple cardiac risk indices have been developed, as well as guidelines for preoperative cardiac evaluation. In 1986, Detsky, et al., modified the original Goldman criteria (1977) adding unstable angina and pulmonary edema to the variables7. A point scale is assigned to each variable, which are then added to determine the patients class and cardiac risk.
Detskys Modified Cardiac Risk Index7 (Chart 1) Age > 70 years old Myocardial Infarction within 6 months Myocardial Infarction after 6 months Canadian Cardiovascular Society (CCS) of Angina (see table below) Class III Class IV Unstable angina within 6 months Alveolar pulmonary edema Within one week Ever Critical Aortic Stenosis Arrhythmia Rhythm other than sinus + PACs > PVCs Emergency Operation Poor General Medical Status Points 5 10 5 10 20 10 10 5 20 5 5 10 5
2005 Tan
Detskys Modified Cardiac Risk Index(cont)7 Class I II III Points 0-15 20-30 31+
(Chart 2) Cardiac Risk Low High
CCS Classification of Angina (Chart 3) 0 asymptomatic I Angina with strenuous exercise II Angina with moderate exertion III Angina with walking 1-2 blocks or climbing one flight of stairs or less at normal pace IV Inability to perform any activity without angina
In 1999, Lee, et al, revised Goldmans criteria for cardiac risk index and developed six independent predictors/variables which correlated with postoperative cardiac complications. Patients with more than 2 variables have a postoperative cardiac complication rate of ~10% and are considered to be high risk8. Lee Variables 1. high-risk type of surgery 2. ischemic heart disease (includes any of the following: history of myocardial infarction, history of a positive exercise test, current complaint of chest pain that is considered to be secondary to myocardial ischemia, use of nitrate therapy, or electrocardiography with pathologic Q waves) 3. congestive heart failure 4. history of cerebrovascular disease 5. preoperative treatment with insulin 6. preoperative serum creatinine >2.0 mg/dL
Lee Criteria-Revised Cardiac Risk Index8 (Chart 4) Number of Variables Risk of major postoperative cardiac complication 0 0.4% 1 0.9% 2 7.0% 3 11.0% High Risk
Separately, Eagle 1989 and Vanzetto 1996 looked at clinical predictors which could predict the probability of cardiac disease. These clinical predictors are considered low risk variables and are cumulative in predicting morbidity. The Eagle criteria (1989)looked at five clinical predictors of postoperative cardiac events: 1) Q waves on ECG, 2) angina, 3) ventricular ectopy, requiring therapy, 4) diabetes on therapy, and 5) age >70 years old. Patients without clinical predictors had only a 3% incidence of perioperative morbidity. Patients with three or more clinical risk factors had a morbidity rate of 50%. Neither group could be further risk stratified with noninvasive testing13. In 1996, Vanzetto G, et al. added a history of myocardial infarction, ST-segment abnormalities on ECG, hypertension with left ventricular hypertrophy, and history of congestive heart failure to Eagles clinical predictors. A patient with 2 variables is considered low to intermediate risk (3%-10%) and may benefit from further investigation9.
2005 Tan
Low Risk Indices/Variables (Chart 5) Eagle 198913 Q waves on ECG Angina Ventricular ectopy Diabetes Age >70 years old
Vanzetto 19969 Age >70 years Diabetes History of congestive heart failure Previous MI (at any time) Angina (any) Hypertension with severe LVH ST abnormalities on rest ECG Q waves
The American College of Cardiology and the American Heart Association (ACC/AHA) and the American College of Physicians (ACP) have published preoperative guidelines/algorithms. The ACC/AHA created guidelines for Perioperative Cardiovascular Evaluation for Noncardiac Sugery, last updated 200211. Their recommendations are based on a patients clinical predictors, patients functional status, and urgency of the surgery. The American College of Physicians (1997) uses Detskys modified cardiac index to determine whether a patient is Class I(low or intermediate risk) or II/ III(high risk). A Class I patient needs to be further stratified by calculating the number of low risk variables in the Modified Cardiac Risk Index (Eagle and Vanzetto criteria). This determines whether a patient remains a low risk (0-1 cardiac risk factors) or intermediate risk patient (>2 cardiac risk factors). Those intermediate risk patients undergoing vascular surgery are recommended to have further noninvasive testing. High risk patients need further intervention whether it is noninvasive or invasive testing, medical optimization, or modifying/canceling surgery. The main differences in the two guidelines are: ACC/AHA incorporates functional status, ACP DOES NOT ACC/AHA requires noninvasive testing for poor functional status ACP requires noninvasive testing for scheduled vascular surgery Please see the respective links for their algorithms/guidelines.
Assessing Surgical Related Risk

Cardiac Risk Stratification for Noncardiac Surgical Procedures11
High Cardiac Event Risk > 5% Intermediate Cardiac Event Risk < 5%
(Chart 6)
Emergent operations, particularly elderly Aortic and other major vascular surgery Peripheral vascular surgery Prolonged surgical procedures associated with large fluid shifts and/or blood loss Carotid endarterectomy surgery Head and neck surgery Intraperitoneal and intrathoracic surgery Orthopedic surgery Prostate surgery Endoscopic procedures Superficial procedure Cataract surgery Breast surgery
Low Cardiac Event Risk <1%
2005 Tan
REFERENCES:
1
Devereaux, P.J., et al. Are the recommendations to use perioperative -blocker therapy in patients undergoing noncardiac surgery based on reliable evidence? CMAJ 2004; 171(3): 245-247.
2 Poldermans, D., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. NEJM 1999; 341(24):1789-94. 3 Mangano, D.T., et al. Effect of atenolol on the mortality and cardiovascular morbidity after noncardiac surgery. NEJM 1996; 335: 1713-20 4 Wallace, A., Effect of Clonidine on Cardiovascular Morbidity and Mortality after Noncardiac Sugery. Anesthesiology 2004; 101(2): 284-293. 5 Pasternack PF, Grossi EA, Baumann FG, Riles TS, Lamparello PJ, Giangola G, et al. Beta blockade to decrease silent myocardial ischemia during peripheral vascular surgery. Am J Surg. 1989;158:113-6. 6
Oliver MF, Goldman L, Julian DG, Holme I. Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology. 1999;91:951-61.
Detsky AS, Abrams HB, McLaughlin JR, Drucker DJ, Sasson Z, Johnston N, et al. Predicting cardiac complications in patients undergoing noncardiac surgery. J Gen Intern Med. 1986;1:211-9 Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043-1049
9 Vanzetto G, Machecourt J, Blendea D, et al. Additive value of thallium single-photon emission computed tomography myocardial imaging for prediction of perioperative events in clinically selected high cardiac risk patients having abdominal aortic surgery. Am J Cardiol. 1996; 77:143-148 8
Goldman L, Caldera DL, Nussbaum SR, Southwick FS, Krogstad D, Murray B, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845-50
11
10
Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL Jr. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery update: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). 2002.
12
American College of Physicians. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Ann Intern Med 1997;127: 309-12.
13 Eagle KA, Coley CM, Newell JB, Brewster DC, Darling RC, Strauss HW, et al. Combining clin-cal and thallium data optimizes preoperative assessment of cardiac ask before major vascular surgery. Ann Intern Med. 1989;110:859-66 14 Poldermans D, Bax JJ, Kertai MD, Krenning B, Westerhout CM, Schinkel AF, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003;107:1848-51. 15 Kertai MD, Boersma E, Westerhout CM, van Domburg R, Klein J, Bax JJ, et al. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med. 2004;116:96-103.
Lindenauer PK, Pekow P, Wang K, Gutierrez B, Benjamin EM. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA. 2004;291:2092-9. Devereaux PJ, Beattie WS, et al. How strong is the evidence for the use of perioperative blockers in non-cardiac surgery? Systematic review and meta-analysis of randomized controlled trials. BMJ, doi:10.1136.
18 McFalls EO, Ward HB, Moritz TE, et al. Coronary-Artery Revascularization before Elective Major Vascular Surgery. NEJM 2004; 351(27): 2795-2804. 19 ONeil-Callahan K, Katsimaglis G, et al. Statins Decrease Perioperative Cardiac Complications in Patients Undergoing Noncardiac Vascular Surgery. JACC 2005; 45(3): 336-342. 17
16

Cardiac Risk Assessment

Uploaded by

Copyright:

Available Formats

Cardiac Risk Assessment

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Cardiac Risk Assessment

Uploaded by

Copyright:

Available Formats

2005 Tan

Prepared by: Hanny Tan, M.D. Updated: June 14, 2006